HUTCHMED (China) annual r&d spending
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
HUTCHMED (China) R&D Spending Growth & History (HCM)
HUTCHMED (China)'s r&d spending was $148.3M for fiscal 2025.
View full HUTCHMED (China) company overviewHUTCHMED (China) annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $148.3M | −$63.8M | −30.09% |
| 2024 | 2024-12-31 | $212.1M | −$89.9M | −29.77% |
| 2023 | 2023-12-31 | $302.0M | −$84.9M | −21.94% |
| 2022 | 2022-12-31 | $386.9M | $87.8M | +29.36% |
| 2021 | 2021-12-31 | $299.1M | $124.3M | +71.13% |
| 2020 | 2020-12-31 | $174.8M | $36.6M | +26.48% |
| 2019 | 2019-12-31 | $138.2M | $24.0M | +21.05% |
| 2018 | 2018-12-31 | $114.2M | $38.6M | +51.16% |
| 2017 | 2017-12-31 | $75.5M | $8.7M | +12.94% |
| 2016 | 2016-12-31 | $66.9M | $19.5M | +41.17% |
| 2015 | 2015-12-31 | $47.4M | $17.5M | +58.35% |
| 2014 | 2014-12-31 | $29.9M | — | — |
HUTCHMED (China) quarterly r&d spending
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2019 | 2019-12-31 | $37.5M | $12.0M | +47.29% |
| Q3 2019 | 2019-09-30 | $31.4M | $2.8M | +9.66% |
| Q2 2019 | 2019-06-30 | $36.0M | $4.6M | +14.71% |
| Q1 2019 | 2019-03-31 | $33.3M | $4.6M | +16.11% |
| Q4 2018 | 2018-12-31 | $25.4M | — | — |
| Q3 2018 | 2018-09-30 | $28.7M | — | — |
| Q2 2018 | 2018-06-30 | $31.4M | — | — |
| Q1 2018 | 2018-03-31 | $28.7M | — | — |
HUTCHMED (China) r&d spending trends
Over the last five fiscal years, HUTCHMED (China)'s r&d spending decreased from $174.8M to $148.3M, a change of −$26.5M. The latest reported quarter, Q4 2019, shows $37.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HUTCHMED (China) source filings ↗